Systematic genomic and translational efficiency studies of uveal melanoma

• Chelsea Place Johnson ,

  Contributed equally to this work with: Chelsea Place Johnson, Ivana K. Kim, Bita Esmaeli

  Current address: Tango Therapeutics, Cambridge, Massachusetts, United States of America

  Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  http://orcid.org/0000-0002-3218-4022

  ⨯
• Ivana K. Kim ,

  Contributed equally to this work with: Chelsea Place Johnson, Ivana K. Kim, Bita Esmaeli

  Affiliation Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Bita Esmaeli ,

  Contributed equally to this work with: Chelsea Place Johnson, Ivana K. Kim, Bita Esmaeli

  Affiliation Orbital Oncology and Ophthalmic Plastic Surgery Program, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Ali Amin-Mansour,

  Affiliation The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Daniel J. Treacy,

  Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Scott L. Carter,

  Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Eran Hodis,

  Affiliation The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Nikhil Wagle,

  Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Sara Seepo,

  Affiliation The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Xiaoxing Yu,

  Affiliations Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Anne Marie Lane,

  Affiliation Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Evangelos S. Gragoudas,

  Affiliation Ocular Melanoma Center and Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Francisca Vazquez,

  Affiliation The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Elizabeth Nickerson,

  Affiliation The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Kristian Cibulskis,

  Affiliation The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Aaron McKenna,

  Affiliations The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America, Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America

  ⨯
• Stacey B. Gabriel,

  Affiliation The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Gad Getz,

  Affiliation The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Eliezer M. Van Allen,

  Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
• Peter A. C. ‘t Hoen,

  Affiliation Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Levi A. Garraway ,

  * E-mail: levi_garraway@dfci.harvard.edu (LAG); swoodman@mdanderson.org (SEW)

  Current address: Eli Lilly and Company, Indianapolis, Indiana, United States of America

  ¶‡ These authors also contributed equally to this work.

  Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Scott E. Woodman

  * E-mail: levi_garraway@dfci.harvard.edu (LAG); swoodman@mdanderson.org (SEW)

  ¶‡ These authors also contributed equally to this work.

  Affiliations Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• [ view all ]
• [ view less ]